the mole clinic limited Company Information
Company Number
04903102
Website
www.themoleclinic.co.ukRegistered Address
2 bromwich court 1st floor, gorsey lane, coleshill, birmingham, B46 1JU
Industry
Specialist medical practice activities
Telephone
02077341177
Next Accounts Due
May 2024
Group Structure
View All
Shareholders
nevis bidco limited 100%
the mole clinic limited Estimated Valuation
Pomanda estimates the enterprise value of THE MOLE CLINIC LIMITED at £1.8m based on a Turnover of £3.9m and 0.47x industry multiple (adjusted for size and gross margin).
the mole clinic limited Estimated Valuation
Pomanda estimates the enterprise value of THE MOLE CLINIC LIMITED at £5.7m based on an EBITDA of £1.4m and a 4.19x industry multiple (adjusted for size and gross margin).
the mole clinic limited Estimated Valuation
Pomanda estimates the enterprise value of THE MOLE CLINIC LIMITED at £5.3m based on Net Assets of £2.7m and 1.95x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Mole Clinic Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
The Mole Clinic Limited Overview
The Mole Clinic Limited is a live company located in coleshill, B46 1JU with a Companies House number of 04903102. It operates in the specialists medical practice activities sector, SIC Code 86220. Founded in September 2003, it's largest shareholder is nevis bidco limited with a 100% stake. The Mole Clinic Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.9m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Mole Clinic Limited Health Check
Pomanda's financial health check has awarded The Mole Clinic Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 8 measures and has 1 areas for improvement. Company Health Check FAQs
8 Strong
2 Regular
1 Weak
Size
annual sales of £3.9m, make it larger than the average company (£328k)
£3.9m - The Mole Clinic Limited
£328k - Industry AVG
Growth
3 year (CAGR) sales growth of 59%, show it is growing at a faster rate (4.6%)
- The Mole Clinic Limited
4.6% - Industry AVG
Production
with a gross margin of 65.3%, this company has a comparable cost of product (58%)
65.3% - The Mole Clinic Limited
58% - Industry AVG
Profitability
an operating margin of 33.6% make it more profitable than the average company (19%)
33.6% - The Mole Clinic Limited
19% - Industry AVG
Employees
with 29 employees, this is above the industry average (9)
29 - The Mole Clinic Limited
9 - Industry AVG
Pay Structure
on an average salary of £27k, the company has an equivalent pay structure (£27k)
- The Mole Clinic Limited
£27k - Industry AVG
Efficiency
resulting in sales per employee of £133.1k, this is more efficient (£72.8k)
£133.1k - The Mole Clinic Limited
£72.8k - Industry AVG
Debtor Days
it gets paid by customers after 91 days, this is later than average (36 days)
91 days - The Mole Clinic Limited
36 days - Industry AVG
Creditor Days
its suppliers are paid after 91 days, this is slower than average (41 days)
91 days - The Mole Clinic Limited
41 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Mole Clinic Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 282 weeks, this is more cash available to meet short term requirements (79 weeks)
282 weeks - The Mole Clinic Limited
79 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 12.3%, this is a lower level of debt than the average (33.1%)
12.3% - The Mole Clinic Limited
33.1% - Industry AVG
the mole clinic limited Credit Report and Business Information
The Mole Clinic Limited Competitor Analysis
Perform a competitor analysis for the mole clinic limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
the mole clinic limited Ownership
THE MOLE CLINIC LIMITED group structure
The Mole Clinic Limited has no subsidiary companies.
Ultimate parent company
2 parents
THE MOLE CLINIC LIMITED
04903102
the mole clinic limited directors
The Mole Clinic Limited currently has 4 directors. The longest serving directors include Mr Iain Mack (Sep 2003) and Mr Darren Grassby (Aug 2020).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Iain Mack | England | 63 years | Sep 2003 | - | Director |
Mr Darren Grassby | England | 48 years | Aug 2020 | - | Director |
Mr Harvey Ainley | England | 57 years | Feb 2024 | - | Director |
Mr Jeremy Richardson | England | 53 years | Feb 2024 | - | Director |
THE MOLE CLINIC LIMITED financials
The Mole Clinic Limited's latest turnover from August 2022 is £3.9 million and the company has net assets of £2.7 million. According to their latest financial statements, The Mole Clinic Limited has 29 employees and maintains cash reserves of £1.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Aug 2022 | Aug 2021 | Aug 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 3,860,459 | |||||||||||||
Other Income Or Grants | 13,581 | |||||||||||||
Cost Of Sales | 1,354,769 | |||||||||||||
Gross Profit | 2,519,271 | |||||||||||||
Admin Expenses | 1,223,633 | |||||||||||||
Operating Profit | 1,295,638 | |||||||||||||
Interest Payable | 0 | |||||||||||||
Interest Receivable | 606 | |||||||||||||
Pre-Tax Profit | 1,296,244 | |||||||||||||
Tax | 142,478 | |||||||||||||
Profit After Tax | 1,438,722 | |||||||||||||
Dividends Paid | 0 | |||||||||||||
Retained Profit | 1,438,722 | |||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 29 | 18 | 19 | 21 | 17 | 16 | 11 | |||||||
EBITDA* | 1,366,603 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Aug 2022 | Aug 2021 | Aug 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 297,762 | 341,237 | 382,408 | 425,509 | 152,877 | 190,820 | 226,337 | 41,098 | 25,204 | 27,530 | 31,103 | 1,289 | 36,829 | 84,318 |
Intangible Assets | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1,878 | 5,338 |
Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20,226 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 297,762 | 341,237 | 382,408 | 425,510 | 152,878 | 190,821 | 226,338 | 61,325 | 25,205 | 27,531 | 31,104 | 1,290 | 38,707 | 89,656 |
Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Debtors | 965,952 | 762,632 | 470,083 | 257,553 | 159,611 | 157,747 | 152,734 | 56,479 | 81,429 | 120,811 | 163,370 | 218,626 | 151,600 | 143,020 |
Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,478 | 0 | 0 | 0 | 0 |
Cash | 1,845,409 | 660,102 | 454,038 | 729,862 | 561,169 | 641,939 | 291,662 | 317,368 | 119,109 | 110,681 | 0 | 0 | 28 | 79,672 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 2,811,361 | 1,422,734 | 924,121 | 987,415 | 720,780 | 799,686 | 444,396 | 373,847 | 200,538 | 237,970 | 163,370 | 218,626 | 151,628 | 222,692 |
total assets | 3,109,123 | 1,763,971 | 1,306,529 | 1,412,925 | 873,658 | 990,507 | 670,734 | 435,172 | 225,743 | 265,501 | 194,474 | 219,916 | 190,335 | 312,348 |
Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 339,482 | 427,385 | 277,078 | 213,014 | 188,344 | 190,546 | 155,708 | 222,614 | 162,471 | 170,826 | 369,388 | 190,553 | 208,712 | 199,263 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 339,482 | 427,385 | 277,078 | 213,014 | 188,344 | 190,546 | 155,708 | 222,614 | 162,471 | 170,826 | 369,388 | 190,553 | 208,712 | 199,263 |
loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 5,290 | 15,684 | 10,888 | 86,745 | 194,516 | 15,000 | 208,268 | 138,411 | 176,801 |
provisions | 41,351 | 47,018 | 46,603 | 58,542 | 17,270 | 23,937 | 29,598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total long term liabilities | 41,351 | 47,018 | 46,603 | 58,542 | 17,270 | 29,227 | 45,282 | 10,888 | 86,745 | 194,516 | 15,000 | 208,268 | 138,411 | 176,801 |
total liabilities | 380,833 | 474,403 | 323,681 | 271,556 | 205,614 | 219,773 | 200,990 | 233,502 | 249,216 | 365,342 | 384,388 | 398,821 | 347,123 | 376,064 |
net assets | 2,728,290 | 1,289,568 | 982,848 | 1,141,369 | 668,044 | 770,734 | 469,744 | 201,670 | -23,473 | -99,841 | -189,914 | -178,905 | -156,788 | -63,716 |
total shareholders funds | 2,728,290 | 1,289,568 | 982,848 | 1,141,369 | 668,044 | 770,734 | 469,744 | 201,670 | -23,473 | -99,841 | -189,914 | -178,905 | -156,788 | -63,716 |
Aug 2022 | Aug 2021 | Aug 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | 1,295,638 | |||||||||||||
Depreciation | 70,965 | 65,635 | 51,397 | 52,411 | 43,283 | 30,947 | 16,834 | 10,866 | 9,942 | 3,984 | 36,827 | 47,489 | 49,344 | |
Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,877 | 3,460 | 3,456 | |
Tax | 142,478 | |||||||||||||
Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Debtors | 203,320 | 292,549 | 212,530 | 97,942 | 1,864 | 5,013 | 96,255 | -24,950 | -45,860 | -36,081 | -55,256 | 67,026 | 8,580 | 143,020 |
Creditors | -87,903 | 150,307 | 64,064 | 24,670 | -2,202 | 34,838 | -66,906 | 60,143 | -8,355 | -198,562 | 178,835 | -18,159 | 9,449 | 199,263 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | -5,667 | 415 | -11,939 | 41,272 | -6,667 | -5,661 | 29,598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash flow from operations | 1,212,191 | |||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | -20,226 | 20,226 | 0 | 0 | 0 | 0 | 0 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | -5,290 | -10,394 | 4,796 | -75,857 | -107,771 | 179,516 | -193,268 | 69,857 | -38,390 | 176,801 |
share issue | ||||||||||||||
interest | 606 | |||||||||||||
cash flow from financing | 606 | |||||||||||||
cash and cash equivalents | ||||||||||||||
cash | 1,185,307 | 206,064 | -275,824 | 168,693 | -80,770 | 350,277 | -25,706 | 198,259 | 8,428 | 110,681 | 0 | -28 | -79,644 | 79,672 |
overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | 1,185,307 | 206,064 | -275,824 | 168,693 | -80,770 | 350,277 | -25,706 | 198,259 | 8,428 | 110,681 | 0 | -28 | -79,644 | 79,672 |
P&L
August 2022turnover
3.9m
0%
operating profit
1.3m
0%
gross margin
65.3%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2022net assets
2.7m
+1.12%
total assets
3.1m
+0.76%
cash
1.8m
+1.8%
net assets
Total assets minus all liabilities
the mole clinic limited company details
company number
04903102
Type
Private limited with Share Capital
industry
86220 - Specialist medical practice activities
incorporation date
September 2003
age
21
accounts
Audited Abridged
ultimate parent company
previous names
scansol limited (September 2010)
the mole clinic (uk) limited (June 2006)
incorporated
UK
address
2 bromwich court 1st floor, gorsey lane, coleshill, birmingham, B46 1JU
last accounts submitted
August 2022
the mole clinic limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the mole clinic limited.
the mole clinic limited Companies House Filings - See Documents
date | description | view/download |
---|